ICD 10 CM F19.259 | Description & Clinical Information
ICD 10 F19.259 describes a condition in which an individual is unable to cease the use of a psychoactive substance, resulting in chemical changes in the brain that affect the patient’s thoughts, behaviors, and emotions, and is characterized by the presence of an unspecified substance-induced psychotic disorder, with the documentation of a psychoactive substance that is not represented by any other code or a combination of substances, or a nonselective and indiscriminate drug use disorder.
Official Description Of F19.259
The ICD 10 CM book defines ICD 10 code F19.259 as:
Excludes1: other psychoactive substance abuse (F19.1-)
other psychoactive substance use, unspecified (F19.9-)
Includes: polysubstance drug use (indiscriminate drug use)
When To Use F19.259
The diagnosis describes by the ICD 10 CM F19.259 code pertains to psychoactive substance-induced disorders. Psychoactive substances are drugs that alter an individual’s brain function, leading to changes in mood, perception, behavior, and consciousness. The use of such substances can cause a range of effects, including heightened alertness, depression, euphoria, hallucinations, and altered personality.
The effects of psychoactive drugs on a person’s brain can be short or long term, depending on the drug’s potency and the length of use. Continuous use of psychoactive substances can lead to addiction, where the body and mind crave the drug, leading to drug-seeking behaviors despite negative consequences.
A person with substance-induced disorders may exhibit various symptoms depending on the drug type, dosage, and length of use. Some common symptoms include a change in perception of reality, delusions, and hallucinations, which can be auditory, visual, or tactile. In some cases, the patient may also experience suicidal thoughts or behaviors.
Providers diagnose the condition based on the patient’s medical history, signs and symptoms, and physical examination. To confirm the diagnosis, laboratory tests can be done to measure the levels of psychoactive substances and their metabolites in bodily fluids like blood, urine, and hair.
Effective treatment approaches for substance-induced disorders include psychological interventions, like Cognitive Behavioral Therapy (CBT) or psychotherapy, and group therapy. In severe cases, residential treatment centers may be necessary to manage withdrawal symptoms and provide a supportive environment for recovery.
It is crucial to recognize that substance-induced disorders can affect anyone, regardless of age, gender, or socioeconomic status. Early diagnosis and intervention can lead to positive health outcomes and improve the patient’s quality of life. Furthermore, raising awareness of the harms of psychoactive substances can help prevent addiction and other complications. Finally, it is essential to provide support and education to affected individuals and their families as they navigate the challenges of substance-induced disorders.
